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Background: Previous research has demonstrated that hyperglycemia may protect the heart against ischemic
injury. The aim of the present study was to investigate the association between hyperglycemia and myocardial
infarction on cardiovascular autonomic modulation and cardiac oxidative stress profile in rats. Male Wistar rats were
divided into: control (C), diabetic (D), myocardial infarcted (MI) and diabetic infarcted rats (DMI).
Methods: Diabetes was induced by streptozotocin (STZ, 50 mg/Kg) at the beginning of the protocol and MI was
induced by left coronary occlusion 15 days after STZ. Thirty days after streptozocin-induced diabetes,
cardiovascular autonomic modulation was evaluated by spectral analysis, and oxidative stress profile was
determined by antioxidant enzyme activities and superoxide anion, together with protein carbonylation and
redox balance of glutathione (GSH/GSSG).
Results: The diabetic and infarcted groups showed decreased heart rate variability and vagal modulation (p < 0.05);
however, sympathetic modulation decreased only in diabetic groups (p < 0.05). Sympatho/vagal balance and vascular
sympathetic modulation were increased only in the MI group (p < 0.05). Diabetes promoted an increase in catalase
concentration (p < 0.05). Glutathione peroxidase activity was increased only in DMI when compared to the other
groups (p < 0.05). Superoxide anion and protein carbonylation were increased only in MI group (p < 0.05). Cardiac
redox balance, as evaluated by GSH/GSSG, was lower in the MI group (p < 0.05).
Conclusions: These data suggest that hyperglycemia promotes compensatory mechanisms that may offer protection
against ischemia, as demonstrated by increased antioxidants, decreased pro-oxidants and protein damage, possibly
related to the improvements in both redox balance and sympathetic modulation to the heart.
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It is well established that cardiovascular autonomic
neuropathy is a major complication of diabetes. It is a
common manifestation in diabetics and contributes to the
overall clinical pathology [1,2]. In addition, diabetic
cardiomyopathy is a serious diabetes complication, which
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along with decreased systolic function. The predisposing
factors in diabetes are associated with a two – to four –
fold increased risk of coronary heart disease [3].
Despite large body of clinical evidence indicating that
diabetic hearts are more sensitive to ischemic injury,
available data from experimental diabetic animal models
are conflicting. Some studies have shown that the dia-
betic heart is less sensitive to ischemic injury [4-9] while
others have suggested that the diabetic heart would be
more sensitive [10-12]. Several factors have been pro-
posed to account for such discrepancy. Our group hasal Ltd. This is an Open Access article distributed under the terms of the Creative
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in chronic diabetic animals was attenuated after 90 days
of myocardial infarction. This finding was associated
with better profile of calcium handling proteins in left
ventricle of diabetic infarcted rats [13]. Additionally, the
activation of hypoxia-inducible factor (HIF-1) was corre-
lated with hypoxia-induced angiogenesis before and
15 days after myocardial infarction induced a reduction
of fibrosis in diabetic animals (30 days of diabetes) [7].
Furthermore, after myocardial infarction the blood flow
in the heart is reduced, decreasing the substrates which
are essential to myocardium workload. This pathological
condition favors an imbalance between reactive oxygen
species (ROS) production and the protective antioxidant
defense system, thereby increasing ROS mediated oxida-
tive stress [14]. Moreover, it is well established that in-
creased oxidative stress plays a critical role in diabetes
complications, as demonstrated by increased levels of
oxidized DNA, proteins and lipids in diabetic subjects
[15]. However, the role of ROS in the cardiac response of
diabetic hearts to myocardial infarction remains unclear.
A fuller understanding of the mechanisms underlying
ROS generation and reactivity may result in new inter-
vention strategies, which might contribute to reduce the
cellular damage associated with oxidative stress in dia-
betic hearts after ischemic injury. Therefore, the aim of
the present study was to investigate the association be-
tween hyperglycemia and myocardial infarction in car-
diovascular autonomic modulation and cardiac oxidative
stress profile in rats undergoing 15 days of ischemia.
Materials and methods
Experimental design
All experimental procedures were conducted according
to the Guidelines for the Use and Care of Animals Re-
search issued by the National Institute of Health, and
complied with the ARRIVE guidelines for reporting ani-
mal research [16]. The study protocol was approved by
the Ethics Research Committee of Nove de Julho
University (process N° 00013/2012). Experiments were
performed using adult male Wistar rats (2–3 months
old, 250–270 g) from the animal facility at the Nove de
Julho University (São Paulo, Brazil). The rats were fed
standard laboratory chow and water ad libitum. They
were housed in collective polycarbonate cages in a
temperature-controlled room (22°C) with a 12-hour
darklight cycle. The rats were randomly assigned to 4
groups (n = 8, per group): control (C), diabetic (D),
myocardial infarcted (MI), and diabetic myocardial
infarcted (DMI) rats.
Diabetes (D and DMI groups) was induced on the first
day of the experiments. On the 15th day of protocol
(15 days after diabetes induction), myocardial infarction
was induced in both DMI and the MI groups. Bodyweight was evaluated weekly. All groups were assessed
for 30 days and hemodynamic, cardiovascular autonomic
modulation and oxidative stress evaluations were per-
formed 30 days after buffer or STZ injection, and 15 days
after MI, as previously described [7].
Induction of diabetes
On the first day of the experiment a single injection of
streptozotocin (STZ, 50 mg/kg, iv; Sigma Chemical Co.,
St. Louis, MO, USA, dissolved in citrate buffer, pH 4.5)
was given to male adult rats (2–3 months old, 250-
270 g, to induce diabetes (D and DMI groups) while C
and MI rats received a single injection of citrate buffer.
Blood glucose was measured to confirm the diabetic-
induced hyperglycaemia at the beginning of the 30-day
protocol after STZ injection (Accu-Check Instant test,
Boehringer Mannheim).
Induction of myocardial infarction
Fifteen days after diabetes induction or administration of
citrate buffer, rats of MI and DMI groups were anaesthe-
tized (80 mg/kg ketamine and 12 mg/kg xylazine, i.p.)
and underwent induction of MI by surgical occlusion of
the left coronary artery, as described elsewhere [7,17].
Briefly, left thoracotomy was performed, the third inter-
costal space dissected, and the heart exposed. The left
coronary artery was occluded with a single nylon (6.0)
suture at approximately 1 mm distal to the left atrial ap-
pendage. The chest was closed with silk suture. The ani-
mals were maintained under ventilation until recovery.
Animals in the (C) and (D) groups underwent sham sur-
gery without induction of myocardial infarction.
Myocardial infarction size
Myocardial infarction size was estimated on the 16th
day of protocol (one day post myocardial surgery) and at
the end of protocol (30th of protocol) on the basis of
subjective identification of akinesia or dyskinesias. MI
size % of left ventricle (LV) perimeter was measured as
the ratio of these regions to the total perimeter of the
endocardial border of the LV. To confirm the echo-
cardiography measurement, the MI size was also evalu-
ated by dissecting the fibrous scar from the remaining
LV muscle [7].
Heart rate and arterial pressure variabilities
One day after the final echocardiographic evaluation
(31 days of protocol) two catheters filled with 0.06 ml of
saline were implanted; one into the right carotid artery
to capture blood pressure (BP) signals, and a second one
into the jugular vein for saline administration of each
anesthetized rat (80 mg/Kg ketamine and 12 mg/Kg
xylazine, i.p). Twenty-four hours later (32 days of proto-
col), the arterial catheter was connected to a strain
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Torrington, CT, USA), and BP signals were recorded
over a 30 minutes period in conscious animals using a
microcomputer equipped with an analog-to-digital con-
verter board (WinDaq, 2 kHz, DATAQ, Springfield, OH,
USA). The recorded data were analyzed on a beat-to-
beat basis to quantify changes in the systolic (SBP),
diastolic (DBP) and mean BP (MAP) and heart rate (HR).
The total power of heart rate variability (HRV) and
systolic blood pressure variability (BPV) were evaluated
using BP recordings obtained in conscious rats at rest
(continuous 30 minutes, 2000 Hz). Overall variability of
HR and SBP were assessed in the time domain by means
of variance. HR and SBP fluctuations were assessed in
the frequency domain by using autoregressive spectral
analysis, as described elsewhere [18]. Briefly, HR and
SBP series were divided into segments of 350 beats and
overlapped by 50%. A spectrum was obtained for each of
the segments via the Levinson-Durbin recursion, with
the model order chosen according to Akaike's criterion,
ranging between 10 and 14. The oscillatory components
were quantified in low (LF: 0.2 to 0.75 Hz) and high
(HF: 0.75 to 3.0 Hz) frequency ranges [19]. The power
spectrum density was calculated for each recognizable
component in the LF and HF bands by integrating the
spectrum of the components. The power is expressed as
LF and HF power, as described elsewhere [20].
Oxidative stress profile
After cardiovascular evaluations, on the 32nd day of
protocol the animals were euthanized by decapitation;
the left ventricle (LV) was rapidly removed, washed in
saline phosphate buffer (PBS), weighed and frozen
at −70°C for oxidative stress analyses.
Approximately ~100 mg of the LV apices were used
for evaluation of the GSH/GSSG. The remaining LV
(ratio of 1 gram of tissue/5 ml of 150 mmol/L of KCl
and 20 nmol/L of phosphate buffer, pH 7.4, with 20 mM
phenylmethylsulfonyl fluride proteases inhibitor solu-
tion) was cut into small pieces, placed in ice-cold buffer
and homogenized using an Ultra Turrax blender. The
LV homogenate was then centrifuged at 600 g for 10 -
minutes at 2°C to remove nuclei and cell debris, as
described elsewhere [21]. The protein content of LV
homogenate was measured by the Lowry method [22],
using bovine serum albumin as the standard.
Antioxidant enzymes
Superoxide dismutase (SOD) activity was measured spec-
trophotometrically in LV homogenates by rate inhibition
of pyrogallol autooxidation at 420 nm [23]. Enzyme activ-
ity was reported as U/mg protein. Catalase (CAT) activity
was determined in LV homogenates by measuring the
decreased absorbance (240 nm) of hydrogen peroxide(H2O2). The results are expressed as nmol of reduced
H2O2/min/mg protein [24]. Glutathione peroxidase (GPx)
activity was assessed in LV homogenates by adding to the
assay a mixture of 1 U/mL glutathione reductase and
2 mmol/L glutathione in 1 mL phosphate buffer. Mixtures
were preincubated at 37°C for 30 minutes. Subsequently,
NADPH and tert-butylhydroperoxide were added, and the
change in absorbance at 340 nm was recorded to calculate
GPx activity, as previously described [25,26].
Superoxide anion
The superoxide anion was determined in LV homoge-
nates by calculating the rate of oxidation of adrenaline at
480 nm, as described by McCord and Fridovich [27].
Since other reactive oxygen species than anion super-
oxide can also oxidize adrenaline, we added SOD to the
assay and observed a critical inhibition of the reaction,
suggesting that this anion might play the most influen-
tial role in this assay.
Protein carbonylation
This method uses the a reaction of protein carbonyl
groups with 2,4- dinitro phenylhydrazine (DNPH) to
form a 2,4-dinitrophenylhydrazone. The product of the
reaction was measured at 360 nm, as previously de-
scribed [28]. The concentration of the carbonyl in LV
homogenates was standardized on the protein unit
(nmol carbonyl group/mg protein) in homogenates of
LV. The amount of protein was calculated from the
bovine serum albumin dissolved in guanidine hydro-
chloride and read at 280 nm. Results were expressed as
nmDNPH/mg protein.
Thiobarbituric acid reaction (TBARS)
For the TBARS assay, trichloroacetic acid (10%, w/v)
was added to the LV homogenates to precipitate pro-
teins and to acidify the samples [29]. This mixture was
then centrifuged (10006 g, 3 minutes), the protein-free
sample was extracted, and thiobarbituric acid (0.67%,
w/v) was added to the reaction medium. The tubes were
placed in a water bath (100°C) for 15 minutes. The
absorbances were measured at 535 nm using a spectro-
photometer. Commercially available malonyldialdehyde
(MDA) was used as a standard, and the results are
expressed as nmoles/mg protein.
Determination of oxidized and reduced glutathione
concentration
In order to determine the concentrations of reduced form
(GSH) and oxidized glutathione form (GSSG), the LV tis-
sue (~100 mg) was deproteinized with 2 mol/L perchloric
acid and centrifuged (1000 g, 10 minutes) while the super-
natant was neutralized with 2 mol/L potassium hydroxide.
The reaction medium contained 100 mmol/L phosphate
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tide phosphate (NADPH), 0.2 U/mL glutathione reduc-
tase, and 70 mmol/L 5, 50 dithiobis (2-nitrobenzoic acid).
To determine reduced glutathione, the supernatant was
neutralized with 2 mol/l potassium hydroxide to react
with 70 mmol/L 5, 50 dithiobis (2-nitro benzoic acid), and
absorbance values were measured at 420 nm [30].
Statistical analysis
Data are reported as means ± SEM. After confirming
that all continuous variables were normally distributed
using the Kolmogorov-Smirnov test. One-way or two-
way ANOVA followed by the Student-Newman-Keuls
post-hoc test was used to compare groups. Pearson
correlation was used to study the association between
variables. Differences were considered significant at
p ≤ 0.05 for all tests. Calculations were performed with
Statistical Package for Social Sciences (SPSS) software,
version 12.0.
Results
Animals
At the beginning of the protocol, body weight was not
statistically different between study groups (C: 280 ± 17;
D: 298 ± 10; MI: 313 ± 4; DMI: 271 ± 4.5 g). Diabetes in-
duced decreases in body weight at the end of the experi-
mental protocol (D: 297 ± 15 g and DMI:309 ± 10 g)
when compared to the non-diabetic groups (C: 400 ± 10
and MI: 394 ± 13 g). Furthermore, the STZ-diabetic rats
(D: 415 ± 22 and DMI: 385 ± 25 mg/dL) had higher
plasma glucose levels when compared to the normogly-
cemic rats (C: 88 ± 4 and MI: 92 ± 3 mg/dL).
Interestingly, at the end of protocol the akinetic area
in the diabetic group was smaller (DMI: 24 ± 3% of LV
perimeter) when compared to the MI group (39 ± 2% of
LV perimeter).
Hemodynamic measurements
SBP remained the same for all groups (C: 123 ± 6; D:
112 ± 4; MI: 122 ± 6; DMI: 111 ± 3 mmHg). DBP was
decreased after diabetes and myocardial infarction (D:
82 ± 2; MI: 82 ± 2; DMI: 89 ± 3 mmHg) when compared
to controls (96 ± 2 mmHg). MBP was reduced in
diabetic group (D: 92 ± 2 mmHg) when compared to
control group (C: 105 ± 2 mmHg), and was not altered
after myocardial infarction (MI: 95 ± 3 and DMI: 96 ±
3 mmHg).
HR was increased after myocardial infarction (MI: 358 ±
4 and DMI: 358 ± 13 bpm) when compared to D and C
groups (316 ± 9 and 330 ± 10 bpm, respectively).
Heart rate and blood pressure variability
Table 1 shows that the D, MI and DMI groups present
decreases in heart rate variance and vagal modulation(the absolute power of the HF) when compared to C
group. The diabetic groups (D and DMI) promoted a
decrease in sympathetic modulation to the heart (the
absolute power of LF) when compared to C and MI
groups. However, the normalized power of HF compo-
nent of HRV was decreased in the MI group when com-
pared to C, D and DMI groups, while the normalized
power of the LF component of HRV was increased in
the MI group when compared to C, D and DMI groups.
Therefore, the sympathovagal balance (LF/HF) was
increased only in the MI group when compared to the
other studied groups.
In addition, vascular sympathetic modulation (LF
band) was increased in MI group in relation to the
other groups (Table 1). Systolic BP variance was de-
creased in diabetic groups (D and DMI) when com-
pared to the C group; however, this parameter was
increased in the MI group when compared to the other
studied groups (Table 1).
Oxidative stress profile
Myocardial infarction induced an increase in cardiac
membrane lipid peroxidation, as assessed by TBARS
(MI: 6 ± 0.4 vs. D: 4 ± 0.5; DMI: 4 ± 0.5 and C: 4 ±
0.3 mmol/mg protein) (Figure 1A), and increased pro-
tein carbonylation (MI: 2.65 ± 0.36 vs. D: 1.5 ± 0.24;
DMI: 1.22 ± 0.2 and C: 1.45 ± 0.26 nmol/mg protein)
when compared to the other studied groups (Figure 1B).
Increases in these parameters of damage were not found
in either D or DMI groups. In addition, the levels of super-
oxide anion increased in the MI group when compared to
the others groups (MI: 7 ± 0.9 vs. D: 4 ± 0.5; DMI: 4 ± 0.5
and C: 4 ± 0.4 O2− mmol/mg protein) (Figure 2A).
These changes were accompanied by significant alter-
ations in cardiac antioxidant enzymes. Diabetes promoted
an increase in CAT activity (DMI: 0.62 ± 0.1; D: 0.56 ± 0.09
vs. IM: 0.35 ± 0.02 and C: 0.29 ± 0.05 nmol/mg protein)
(Figure 2B). However, GPx activity was increased only in
the DMI group (0.04 ± 0.008 μmol/min/mg protein)
when compared to the other groups (MI: 0.02 ± 0.0002;
D: 0.02 ± 0.003; and C: 0.01 ± 0.005 μmol/min/mg
protein) (Figure 2C). SOD activity was not statistically
different between groups (C: 4.32 ± 0.62; D: 5.38 ± 0.82;
MI: 6.27 ± 1.1 and DIM: 5.22 ± 0.63 USOD/mg protein)
(Figure 2D).
The GSH/GSSG ratio was reduced only in MI group
(8.5 ± 1.2) when compared to the other studied groups
(C: 14 ± 3; D: 16 ± 3; DMI: 17 ± 1.4) (Figure 3).
Correlation analysis
Correlations between cardiac sympathetic modulation
(LF band) and CAT (r = − 0.68; p < 0.0006, Figure 4A), and
superoxide anion (r = 0.7; p < 0.0001, Figure 4B.) were
found using Pearson correlation analysis and involved all
Table 1 Cardiovascular autonomic modulation in studied groups
Measurements C D MI DMI
HRV
Variance (ms2) 122 ± 15 35 ± 4.0* 39.5 ± 6.0* 23 ± 2.5*
LF (ms2) 3.0 ± 0.28 1.3 ± 0.36 *† 4.0 ± 0.53 1.2 ± 0.10*†
LF (NU) 20 ± 1 14 ± 3† 36.3 ± 3.2* 12 ± 1.6†
HF (ms2) 12 ± 1.0 6.7 ± 0.7* 5.3 ± 0.9* 6. ± 0.6*
HF (NU) 80 ± 1 86 ± 3† 64 ± 3.2* 88 ± 1.6†
LF/HF 0.26 ± 0.02 0.11 ± 0.02*† 0.40 ± 0.04* 0.14 ± 0.02*†
BPV
Variance (mm Hg2) 28 ± 4.0 9 ± 1.3*† 49 ± 7.5* 2 ± 0.3*†
LF (mm Hg2) 2.5 ± 0.80 1.0 ± 0.16*† 6 ± 0.53* 1.0 ± 0.09*†
Systolic blood pressure (BPV) and heart rate (HRV) variabilities computed from 0.20 to 3 Hz (total power), low-frequency (LF: 0.20-0.75 Hz) and high-frequency (HF:
0.75-3 Hz) bands of control (C), diabetic (D), myocardial infarcted (MI) and diabetic myocardial infarcted (DMI) rats. Data are reported as mean ± SEM. *p ≤ 0.05
compared with C; †p ≤ 0.05 compared with MI.
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associated with both lower CAT concentration and higher
levels of superoxide anion. Moreover, a significant inverse
correlation between vascular sympathetic modulation (LF
band) with cardiac GSH/GSSG ratio (r = − 0.60; p < 0.05,
Figure 4C.) was also found, with higher vascular LF band
being associated with lower glutathione redox balance.†
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Figure 1 Oxidative stress profile of left ventricle homogenates in
control (C), diabetes (D), myocardial infarction (MI), and
diabetes +myocardial infarction (DMI) rats (n = 8 for each group).
A: Lipid peroxidation indicated by thiobarbituric acid-reactive substances
(TBARS). B: protein carbonylation. *p < 0.05 vs. C; †p < 0.05 vs. MI.Discussion
Hyperglycemia leads to abnormalities in several organs
and these damages in turn increase the morbidity and
mortality in diabetic individuals. However, some studies
have suggested that hyperglycemia may offer a protective
effect against myocardial ischemia, but these findings
remain controversial. To understand the positive role of
hyperglycemia on gene regulators of cell survival, the
present study investigated the effects of 15 days of myo-
cardial infarction on cardiac autonomic modulation and
on oxidative stress profile in STZ-diabetic rats (30 days).
The key finding of the present study lies in the fact that
the myocardial infarction induced increase in cardiac
and vascular sympathetic modulation was attenuated in
diabetic infarcted rats, and this change was associated
with improvement in cardiac oxidative stress profile.
The present study corroborates a previous study
undertaken by our group; in that study we found a simi-
lar metabolic damage induced by STZ diabetes [31-33].
The diabetic groups in this study presented a statistically
significant increase in glycemia and reduction in body
weight, therefore demonstrating a significant metabolic
state which closely resembles humans with uncontrolled
diabetes. Interestingly, some studies [34-36] have re-
ported conflicting data about the role of hyperglycemia
in the mechanisms that would account for cardioprotec-
tion in diabetic animals. Researchers have observed a
pronounced reduction in the myocardial infarction area
in diabetic animals, which may be a result of increased
availability and use of glucose, the heart’s preferred
energy substrate during a stress [9,37,38]. These studies
showed that the hyperglycemic conditioning before
ischemia leads to a cardioprotective condition; however,
the underlying protective mechanisms should be further
studied.
The leading cause of the higher resistance of diabetic
rats to ischemic injury may be associated with the
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Figure 2 Oxidative stress profile of left ventricle homogenates in control (C), diabetes (D), myocardial infarction (MI), and diabetes +
myocardial infarction (DMI) rats (n = 8 for each group). A: superoxide anion. B: catalase activity. C: superoxide dismutase activity. D: glutathione
peroxidase activity. *p < 0.05 vs. C; †p < 0.05 vs. MI; ‡p < 0.05 vs. D.
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by the reduced fibrosis area and the number of dead
myocytes [40]. These suggest an improvement in
systolic function generated by decreased pro-inflammatory
cytokines in diabetic animals [7].
Although diabetes worsens global left ventricular func-
tion, it protects the ischemic area, leading to increased
expression of cell survival proteins and decreased infarct
size [9]. In fact, in the present study we observed that
after 15 days of myocardial infarction, diabetic animals0.00
5.00
10.00
15.00
20.00
C D MI DMI
†
Figure 3 Oxidized (GSH) and reduced glutathione (GSSG) ratio
in left ventricle tissue in control (C), diabetes (D), myocardial
infarction (MI), and diabetes +myocardial infarction (DMI) rats
(n = 8 for each group). †p < 0.05 vs. MI.presented a statistically significant reduction in the
akinetic area, as previously described by our group (DMI
animals compared to MI animals) [7]. This finding could
be associated with an increase in survival pathways, such
as anti-apoptotic factor (Bcl-2), protein kinase B (Akt),
protein Kinase C-ε (PKC-ε), HIF-1 and vascular endo-
thelial growth factor (VEGF). Accordingly, capillary
density may effectively contribute to the reduction of
ischemic injury and cardiac fibrosis in diabetic animals.
These alterations might play an important role in
improving heart function and increasing glucose trans-
porter type 1 expression, which in turn may be critical
for glucose uptake in ischemic conditions in diabetic
infarcted rats [41].
Hemodynamic and cardiovascular autonomic modulation
DBP was reduced in DMI group and this change in BP
may be related to cardiovascular autonomic neuropathy,
which has been regarded as a major determinant of
mortality in diabetic patients, regardless of other known
risk factors [42]. Indeed, in line with these findings, in
the present study both the diabetic and infarcted groups
showed a statistically significant decrease in heart rate
variance and vagal modulation.
To further investigate the mechanisms underlying the
improved tolerance to ischemia in diabetic rats (DMI
group) we evaluated the cardiac autonomic modulation
of the experimental groups. Interestingly, our data indi-
cate that diabetes attenuated the sympathetic dysfunc-
tion caused by myocardial ischemia. The vascular and
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Figure 4 Pearson correlation analysis involving animals of all groups (C; D; MI and DMI). A: Cardiac sympathetic modulation (LF band of
PI) and catalase. B: Cardiac sympathetic modulation (LF band of PI) and superoxide anion. C: Vascular sympathetic modulation (LF band of SAP)
and GSH/GSSG ratio.
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the cardiac sympathovagal balance, were increased in MI
when compared to DMI group (p < 0.05). Possibly, this
cardiovascular autonomic dysfunction might lead to
cardiovascular damage in the long-term (more than
30 days), and might be related to the increased mortality
rate found in diabetic rats after a long-term myocardial
infarction (90 days) [43]. Therefore, short-term hyper-
glycemia may protect the heart against an ischemic
insult, reducing cardiovascular sympathetic modulation
and preserving ventricular function.
Cardiac oxidative stress profile
To investigate the intracellular mechanisms contributing
to the attenuation of sympathetic modulation, we
evaluated the oxidative stress profile in the LV tissue.
Myocardial infarction in normoglicemic rats promoted
a reduction of GPx activity, an increase in superoxide
anion, lipoperoxidation and protein carbonilation, as
well as a decrease in GSH/GSSG (p < 0.05 vs. C group),
thus showing a worsened redox balance after ischemia.
Therefore, these results combined may contribute to
the imbalance of survival factors after myocardial
infarction, through the increase in proapoptotic pro-
tein expression [44].
Hyperglycemia or myocardial infarction leads to oxi-
dative stress and several other another abnormalities,
causing changes in cellular signaling. These diabetes-
mediated biochemical anomalies cross-interact in acomplex interplay. These changes also lead to an alter-
ation of transcriptional and post-transcriptional ma-
chinery, resulting in altered production of vasoactive
and cardioactive factors by augmented production of
reactive oxygen species such as superoxide (O2
−),
hydroxyl (OH−) and non-radicals, consequently reducing
antioxidant defenses [14,45]. Therefore, these findings seem
to depend on the period of hyperglycemia exposition. In
this sense, STZ-induced diabetes in aged spontaneously
hypertensive rats showed that the cardiac remodeling is
associated with increased oxidative stress and activated fetal
gene program [46].
In fact, short-term hyperglycemia initiates compensa-
tory mechanisms. In this sense we demonstrated for the
first time a statistically significant increase in antioxidant
enzyme activity (CAT and GPx) and decrease in
superoxide anion levels, lipoperoxidation and protein
carbonilation, along with an increase in GSH/GSSG
in diabetic animals after myocardial infarction (DMI
group) when compared to normoglycemic animals (MI
group) (p < 0.05). This indicates a reduced LV oxidative
stress in infarcted animals previously exposed to
hyperglycemia. These changes may be related to our
previous findings, which demonstrated improvements
in the ventricular response and infarcted area, and
increased CAT activity and mortality rate in diabetic
rats evaluated for short- term hyperglycemia (14 days
after diabetes induction and exposed to 7 days of ischemic
injury) [13].
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species to the role of second messenger involved in cell
signalling. The adaptative capacity of the cells is altered
by the balance between death or survival signals, conver-
ging at the level of the mitochondria, with distinct path-
ophysiologic consequences that extends the period of
injury. Altered glucose flux, mitochondrial derangements
and nitric oxide synthase uncoupling in the presence of
decreased antioxidant defense and impaired pro survival
cell signaling may render the diabetic myocardium more
vulnerable to injury, remodelling and heart failure [47].
Additionally, ROS-stimulated activation of PERK (pro-
tein kinase RNA- like ER kinase) signaling pathway plays
a key role in ROS-medicated endoplasmic reticulum
stress-induced myocyte apoptosis in diabetic cardio-
myopathy [48].
Finally, decreased cardiovascular sympathetic modu-
lation may contribute to increase the expression of cell
survival factors and to reduce oxidative stress, thus
decreasing akinetic area and improving systolic func-
tion in diabetic infarcted animals. In this sense, the
Person correlations between cardiac and vascular
sympathetic modulation and LV oxidative stress evalu-
ations (CAT, superoxide anion and GSH/GSSG) found
in the present study reinforce the role of the auto-
nomic nervous system in the management of cellular
responses to ischemia.
In conclusion, our data suggest that hyperglycemia
initiated compensatory mechanisms that may provide
protection against ischemia, as demonstrated by in-
creased antioxidants, decreased pro-oxidants and tis-
sue damage associated with improvements in redox
balance and cardiovascular sympathetic modulation.
Taken together, these positive changes promoted a signifi-
cant reduction in infarcted area, thus enabling cellular
survival with improvement of systolic function.
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